Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.3871
-0.0228 (-5.56%)
At close: Nov 19, 2026, 4:00 PM EST
0.4000
+0.0129 (3.33%)
After-hours: Nov 19, 2026, 7:30 PM EST
Coherus Oncology Employees
Coherus Oncology had 145 employees as of September 30, 2026. The number of employees decreased by 13 or 8.23% compared to the same quarter last year. That makes Coherus Oncology the 29,133rd largest employer in the world and 3,671st in the United States.
Employees
145
Change (1Y)
-13
Growth (1Y)
-8.23%
Revenue / Employee
$369,924
Profits / Employee
-$937,483
Market Cap
59.82M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2026 | 145 | -13 | -8.23% |
| Jun 30, 2026 | 144 | -33 | -18.64% |
| Mar 31, 2026 | 145 | -76 | -34.39% |
| Dec 31, 2025 | 147 | -81 | -35.53% |
| Sep 30, 2025 | 158 | -77 | -32.77% |
| Jun 30, 2025 | 177 | -69 | -28.05% |
| Mar 31, 2025 | 221 | -28 | -11.24% |
| Dec 31, 2024 | 228 | -78 | -25.49% |
| Sep 30, 2024 | 235 | -64 | -21.40% |
| Jun 30, 2024 | 246 | -48 | -16.33% |
| Mar 31, 2024 | 249 | -58 | -18.89% |
| Dec 31, 2023 | 306 | -53 | -14.76% |
| Sep 30, 2023 | 299 | -77 | -20.48% |
| Jun 30, 2023 | 294 | -74 | -20.11% |
| Mar 31, 2023 | 307 | -39 | -11.27% |
| Dec 31, 2022 | 359 | 27 | 8.13% |
| Sep 30, 2022 | 376 | 42 | 12.57% |
| Jun 30, 2022 | 368 | 57 | 18.33% |
| Mar 31, 2022 | 346 | 36 | 11.61% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Champions Oncology | 214 |
| Fortress Biotech | 78 |
| Acrivon Therapeutics | 76 |
| Milestone Pharmaceuticals | 38 |
| Anavex Life Sciences | 34 |
| iBio, Inc. | 23 |
| Cognition Therapeutics | 14 |
| Nutriband | 13 |
CHRS News
- 3 days ago - Coherus Oncology Transcript: Jefferies Global Healthcare Conference - Transcripts
- 8 days ago - Oncolytics enters clinical supply agreement with Coherus Oncology - TheFly
- 8 days ago - Coherus Oncology Slides: Corporate presentation - Filings
- 9 days ago - Coherus Oncology reports Q3 EPS (20c), consensus (21c) - TheFly
- 9 days ago - Coherus Oncology price target lowered to $8 from $10 at Guggenheim - TheFly
- 9 days ago - Coherus Oncology Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 10 days ago - Coherus Oncology Earnings Call Transcript: Q3 2026 - Transcripts
- 10 days ago - Coherus Oncology Earnings release: Q3 2026 - Filings